NEWS COMMENTARY

Singapore commences Phase 2 of its National Precision Medicine program

Published:
April 08, 2021
Coverage:
Digital Transformation More...
Activities:
Policy More...
Average importance

Singapore's National Precision Medicine (NPM) program is a 10-year plan aimed at transforming the Singaporean healthcare system by understanding how genomic, phenotypic, lifestyle, and clinical factors contribute to the health of Singaporeans. NPM Phase I began in 2017 and resulted in a databank comprising the genomic data of 10,000 healthy Singaporeans, serving as a benchmark for what "normal" means for Singaporeans. While a good start, 10,000 is still a small number, and Phase 2 aims to scale this even further with 100,000 healthy genomes and 50,000 genomes of patients with specific diseases. This is a good time to consider clinical and research partnerships in Singapore's strong public-private partnership ecosystem. 

For the original news article, click here .


Further Reading

Genomic testing being piloted for precision medicine and preventive health in U.K.

News Commentary | March 25, 2021

The U.K. is widely regarded as a pioneer in human genomics, embarking on the first publicly funded whole‑genome sequencing (WGS) project a few years ago. However, there have been few practical applications in healthcare delivery to date. This could change, as the NHS announced a pilot project with ... To read more, click here.

Pfizer's partnership with Halodoc promises to solve an access issue and create better patient engagement

Case Study | June 10, 2021

Breast cancer is the most prevalent form of cancer in Indonesia, with an incidence of roughly 18.6 cases per 100,000 people annually. Pfizer is an industry leader in innovative breast cancer treatments, although it is facing competition from Novartis and Eli Lilly. The cost of breast cancer drugs ... Not part of subscription

Canadian group builds calculator that predicts when a frail elderly person will die

News Commentary | July 09, 2021

Scientists from Project Big Life, a group dedicated to understanding the trajectory of someone's death to provide appropriate end‑of‑life care, have developed a calculator that predicts how long a frail elderly individual has to live. End‑of‑life care is poised to grow in importance in rapidly aging... Not part of subscription